Please wait
false Q1 --12-31 0001730773 0001730773 2026-01-01 2026-03-31 0001730773 2026-07-16 0001730773 2026-03-31 0001730773 2025-12-31 0001730773 us-gaap:RelatedPartyMember 2026-03-31 0001730773 us-gaap:RelatedPartyMember 2025-12-31 0001730773 BSFC:SeriesASuperVotingConvertiblePreferredStockMember 2026-03-31 0001730773 BSFC:SeriesASuperVotingConvertiblePreferredStockMember 2025-12-31 0001730773 2025-01-01 2025-03-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2025-12-31 0001730773 us-gaap:CommonStockMember 2025-12-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001730773 us-gaap:RetainedEarningsMember 2025-12-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2025-12-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001730773 us-gaap:TreasuryStockCommonMember 2025-12-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2024-12-31 0001730773 us-gaap:CommonStockMember 2024-12-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001730773 us-gaap:RetainedEarningsMember 2024-12-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2024-12-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001730773 us-gaap:TreasuryStockCommonMember 2024-12-31 0001730773 2024-12-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-03-31 0001730773 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001730773 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2026-01-01 2026-03-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001730773 us-gaap:TreasuryStockCommonMember 2026-01-01 2026-03-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2025-01-01 2025-03-31 0001730773 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001730773 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2025-01-01 2025-03-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001730773 us-gaap:TreasuryStockCommonMember 2025-01-01 2025-03-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2026-03-31 0001730773 us-gaap:CommonStockMember 2026-03-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001730773 us-gaap:RetainedEarningsMember 2026-03-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2026-03-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001730773 us-gaap:TreasuryStockCommonMember 2026-03-31 0001730773 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2025-03-31 0001730773 us-gaap:CommonStockMember 2025-03-31 0001730773 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001730773 us-gaap:RetainedEarningsMember 2025-03-31 0001730773 us-gaap:ReceivablesFromStockholderMember 2025-03-31 0001730773 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001730773 us-gaap:TreasuryStockCommonMember 2025-03-31 0001730773 2025-03-31 0001730773 BSFC:GaultSeafoodLLCMember BSFC:AssetPurchaseMember 2022-02-01 2022-02-03 0001730773 BSFC:MasterServiceAgreementMember BSFC:AfritexVenturesIncMember 2024-02-01 2024-02-01 0001730773 BSFC:OptionAgreementMember BSFC:AfritexVenturesIncMember 2024-02-12 2024-02-12 0001730773 BSFC:OptionAgreementMember BSFC:AfritexVenturesIncMember BSFC:SharesHeldInEscrowMember 2024-02-12 2024-02-12 0001730773 2024-05-20 2024-05-20 0001730773 us-gaap:EquipmentMember 2026-03-31 0001730773 BSFC:RealPropertyMember srt:MinimumMember 2026-03-31 0001730773 BSFC:RealPropertyMember srt:MaximumMember 2026-03-31 0001730773 2025-01-01 2025-12-31 0001730773 us-gaap:FairValueInputsLevel3Member 2026-03-31 0001730773 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001730773 us-gaap:MeasurementInputSharePriceMember 2025-12-31 0001730773 us-gaap:MeasurementInputExpectedDividendRateMember 2025-12-31 0001730773 us-gaap:MeasurementInputPriceVolatilityMember srt:MinimumMember 2025-12-31 0001730773 us-gaap:MeasurementInputPriceVolatilityMember srt:MaximumMember 2025-12-31 0001730773 us-gaap:MeasurementInputRiskFreeInterestRateMember 2025-12-31 0001730773 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2025-01-01 2025-12-31 0001730773 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2025-01-01 2025-12-31 0001730773 us-gaap:MeasurementInputSharePriceMember 2026-03-31 0001730773 us-gaap:MeasurementInputExpectedDividendRateMember 2026-03-31 0001730773 us-gaap:MeasurementInputPriceVolatilityMember 2026-03-31 0001730773 us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-03-31 0001730773 us-gaap:MeasurementInputExpectedTermMember srt:MinimumMember 2026-01-01 2026-03-31 0001730773 us-gaap:MeasurementInputExpectedTermMember srt:MaximumMember 2026-01-01 2026-03-31 0001730773 us-gaap:ComputerEquipmentMember 2026-03-31 0001730773 us-gaap:ComputerEquipmentMember 2025-12-31 0001730773 BSFC:RASSystemMember 2026-03-31 0001730773 BSFC:RASSystemMember 2025-12-31 0001730773 us-gaap:AutomobilesMember 2026-03-31 0001730773 us-gaap:AutomobilesMember 2025-12-31 0001730773 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001730773 us-gaap:LeaseholdImprovementsMember 2025-12-31 0001730773 BSFC:SecuritiesPurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember 2023-05-30 0001730773 BSFC:SecuritiesPurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember srt:MaximumMember 2023-05-30 0001730773 2023-05-30 0001730773 BSFC:LindGlobalFundTwoLPMember 2023-05-30 2023-05-30 0001730773 BSFC:LindGlobalFundTwoLPMember 2023-05-30 0001730773 BSFC:PurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember BSFC:SeniorConvertiblePromissoryNoteMember 2023-07-27 0001730773 BSFC:PurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember 2023-07-27 0001730773 BSFC:PurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember 2023-07-27 2023-07-27 0001730773 BSFC:PurchaseAgreementMember BSFC:LindGlobalFundTwoLPMember 2024-08-03 0001730773 BSFC:WaiverAgreementMember BSFC:LindGlobalFundTwoLPMember 2024-08-03 0001730773 BSFC:LindGlobalFundTwoLPMember BSFC:WaiverAgreementMember 2026-03-31 0001730773 BSFC:LindGlobalFundTwoLPMember BSFC:WaiverAgreementMember 2025-12-31 0001730773 BSFC:ThirdPartyInvestorsMember 2025-01-28 2025-01-28 0001730773 BSFC:ThirdPartyInvestorsMember 2025-02-07 2025-02-07 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:LoanMember 2026-03-31 0001730773 BSFC:ConvertiblePromissoryNoteFourMember BSFC:ThirdPartyInvestorsMember 2025-01-28 0001730773 BSFC:ConvertiblePromissoryNoteFourMember BSFC:ThirdPartyInvestorsMember 2025-01-28 2025-01-28 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteFourMember 2026-01-01 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteFourMember 2025-01-01 2025-12-31 0001730773 BSFC:ConvertiblePromissoryNoteFiveMember BSFC:ThirdPartyInvestorsMember 2025-08-25 0001730773 BSFC:ConvertiblePromissoryNoteFiveMember BSFC:ThirdPartyInvestorsMember 2025-08-25 2025-08-25 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteFiveMember 2026-01-01 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteFiveMember 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteFiveMember 2025-12-31 0001730773 BSFC:ConvertiblePromissoryNoteSixMember BSFC:ThirdPartyInvestorsMember 2025-12-05 0001730773 BSFC:ConvertiblePromissoryNoteSixMember BSFC:ThirdPartyInvestorsMember 2025-12-05 2025-12-05 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteSixMember 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteSixMember 2025-12-31 0001730773 BSFC:ConvertiblePromissoryNoteSevenMember BSFC:ThirdPartyInvestorsMember 2025-09-16 0001730773 BSFC:ConvertiblePromissoryNoteSevenMember BSFC:ThirdPartyInvestorsMember 2025-09-16 2025-09-16 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteSevenMember 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteSevenMember 2025-12-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteSevenMember 2026-01-01 2026-03-31 0001730773 BSFC:ConvertiblePromissoryNoteEightMember BSFC:ThirdPartyInvestorsMember 2025-11-13 0001730773 BSFC:ConvertiblePromissoryNoteEightMember BSFC:ThirdPartyInvestorsMember 2025-11-13 2025-11-13 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteEightMember 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteEightMember 2025-12-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteEightMember 2026-01-01 2026-03-31 0001730773 BSFC:ConvertiblePromissoryNoteNineMember BSFC:ThirdPartyInvestorsMember 2025-09-18 0001730773 BSFC:ConvertiblePromissoryNoteNineMember BSFC:ThirdPartyInvestorsMember 2025-09-18 2025-09-18 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteNineMember 2026-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteNineMember 2025-03-31 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteNineMember 2026-01-01 2026-03-31 0001730773 BSFC:ConvertiblePromissoryNoteTenMember BSFC:ThirdPartyInvestorsMember 2026-03-10 0001730773 BSFC:ConvertiblePromissoryNoteTenMember BSFC:ThirdPartyInvestorsMember 2026-03-10 2026-03-10 0001730773 BSFC:ThirdPartyInvestorsMember BSFC:ConvertiblePromissoryNoteTenMember 2026-03-31 0001730773 BSFC:AugustPrivatePlacementOfferingMember BSFC:PrivatePlacementNotesMember 2024-08-31 0001730773 BSFC:AugustPrivatePlacementOfferingMember 2024-08-01 2024-08-31 0001730773 BSFC:AugustPrivatePlacementOfferingMember BSFC:PrivatePlacementNotesMember BSFC:NoteTwoMember 2024-08-31 0001730773 BSFC:AugustPrivatePlacementOfferingMember BSFC:PrivatePlacementNotesMember 2024-08-01 2024-08-31 0001730773 BSFC:AugustPrivatePlacementOfferingMember BSFC:PrivatePlacementNotesMember srt:MinimumMember 2024-08-31 0001730773 BSFC:PrivatePlacementNotesMember 2026-01-01 2026-03-31 0001730773 BSFC:PrivatePlacementNotesMember 2025-01-01 2025-12-31 0001730773 BSFC:PromissoryNoteMember BSFC:UnaffiliatedThirdPartyMember 2025-10-29 0001730773 BSFC:PromissoryNoteMember BSFC:UnaffiliatedThirdPartyMember 2025-10-29 2025-10-29 0001730773 BSFC:PromissoryNoteMember BSFC:UnaffiliatedThirdPartyMember 2026-01-01 2026-03-31 0001730773 BSFC:PromissoryNoteMember BSFC:UnaffiliatedThirdPartyMember 2026-03-31 0001730773 BSFC:PromissoryNoteMember BSFC:UnaffiliatedThirdPartyMember 2025-12-31 0001730773 BSFC:VehicleLoanMember 2024-12-07 2024-12-07 0001730773 BSFC:VehicleLoanMember 2024-12-07 0001730773 BSFC:VehicleLoanMember BSFC:UnaffiliatedThirdPartyMember 2026-01-01 2026-03-31 0001730773 BSFC:VehicleLoanMember 2026-03-31 0001730773 BSFC:VehicleLoanMember 2025-12-31 0001730773 BSFC:ClearThinkCapitalLlcMember 2025-03-11 2025-03-11 0001730773 BSFC:OneThousandEightHundredDiagonalLendingLLCMember 2025-03-12 2025-03-12 0001730773 BSFC:QuickCapitalLlcMember 2025-01-01 2025-03-31 0001730773 BSFC:JeffersonStreetCapitalLlcMember 2025-01-01 2025-03-31 0001730773 BSFC:ClearThinkCapitalLlcMember 2026-01-16 2026-01-16 0001730773 us-gaap:SeriesAPreferredStockMember 2026-01-27 0001730773 us-gaap:SeriesAPreferredStockMember 2026-01-27 2026-01-27 0001730773 2026-01-27 0001730773 2026-01-28 0001730773 BSFC:QuickCapitalLlcMember 2026-01-01 2026-03-31 0001730773 BSFC:OneThousandEightHundredDiagonalLendingLLCMember 2026-01-01 2026-03-31 0001730773 BSFC:LabrysFundMember 2026-01-01 2026-03-31 0001730773 us-gaap:WarrantMember 2025-12-31 0001730773 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001730773 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001730773 us-gaap:WarrantMember 2026-03-31 0001730773 BSFC:PurchaseAgreementAmendmentMember BSFC:LindGlobalFundTwoLPMember 2023-07-27 0001730773 BSFC:ThirdPartyInvestorMember 2025-09-16 0001730773 BSFC:ThirdPartyInvestorMember 2025-09-18 0001730773 BSFC:ThirdPartyInvestorMember 2025-11-13 0001730773 BSFC:ThirdPartyInvestorMember 2026-03-10 0001730773 BSFC:LeaseAgreementMember 2025-01-01 2025-03-31 0001730773 BSFC:LeaseAgreementMember 2026-01-01 2026-03-31 0001730773 BSFC:TasteofBCAquafarmsIncMember 2026-01-01 2026-03-31 0001730773 BSFC:TasteofBCAquafarmsIncMember BSFC:SteveAndJanetAtkinsonMember 2022-04-01 2022-04-01 0001730773 BSFC:TasteofBCAquafarmsIncMember BSFC:KathrynAtkinsonMember 2022-04-01 2022-04-01 0001730773 us-gaap:RelatedPartyMember 2026-01-01 2026-03-31 0001730773 us-gaap:NonrelatedPartyMember 2026-01-01 2026-03-31 0001730773 us-gaap:RelatedPartyMember 2025-01-01 2025-03-31 0001730773 us-gaap:NonrelatedPartyMember 2025-01-01 2025-03-31 0001730773 srt:MinimumMember 2026-01-28 2026-01-28 0001730773 srt:MaximumMember 2026-01-28 2026-01-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:CAD utr:sqft BSFC:Integer BSFC:Segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended: March 31, 2026

 

or

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from ________________ to ________________

 

Commission file number: 001-40991

 

BLUE STAR FOODS CORP.

(Exact name of registrant as specified in its charter)

 

Delaware   82-4270040

(State or other jurisdiction of

incorporation or organization)

 

(IRS Employer

Identification No.)

 

3000 NW 109th Avenue

Miami, Florida 33172

 

(Address of principal executive offices)

 

(305) 836-6858

 

(Registrant’s telephone number, including area code)

 

N/A

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, $0.0001 par value   BSFC   Over The Counter Markets Group

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated Filer Smaller reporting company
    Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

 

As of July 16, 2026, there were 163,880,101 shares of the registrant’s common stock outstanding.

 

 

 

 

 

 

BLUE STAR FOODS CORP.

 

FORM 10-Q

FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2026

 

TABLE OF CONTENTS

 

    PAGE
     
PART I - FINANCIAL INFORMATION 4
     
Item 1. Financial Statements (Unaudited) 4
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 22
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 29
     
Item 4. Controls and Procedures 29
     
PART II - OTHER INFORMATION 30
     
Item 1. Legal Proceedings 30
     
Item 1A. Risk Factors 30
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30
     
Item 3. Defaults Upon Senior Securities 30
     
Item 4. Mine Safety Disclosures 30
     
Item 5. Other Information 30

 

2

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Except for historical information, this report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such forward-looking statements include, among others, those statements including the words “believes”, “anticipates”, “expects”, “intends”, “estimates”, “plans” and words of similar import. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements.

 

Forward-looking statements are based on our current expectations and assumptions regarding our business, potential target businesses, the economy and other future conditions. Because forward-looking statements relate to the future, by their nature, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you therefore that you should not rely on any of these forward-looking statements as statements of historical fact or as guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include changes in local, regional, national or global political, economic, business, competitive, market (supply and demand), regulatory conditions and the following:

 

  Our ability to raise capital when needed and on acceptable terms and conditions;
     
  Our ability to make acquisitions and integrate acquired businesses into our company;
     
  Our ability to attract and retain management with experience in the business of importing, packaging and selling of seafood;
     
  Our ability to negotiate, finalize and maintain economically feasible agreements with suppliers and customers;
     
  The availability of crab meat and other premium seafood products we sell;
     
  The intensity of competition; and
     
  Changes in the political and regulatory environment and in business and fiscal conditions in the United States and overseas.

 

A description of these and other risks and uncertainties that could affect our business appears in the section captioned “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 which we filed with the Securities and Exchange Commission (“SEC”) on May 22, 2026. The risks and uncertainties described under “Risk Factors” are not exhaustive.

 

Given these uncertainties, readers of this Quarterly Report on Form 10-Q (“Quarterly Report”) are cautioned not to place undue reliance on such forward-looking statements. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements contained herein to reflect future events or developments.

 

All references in this Quarterly Report to the “Company”, “we”, “us”, or “our”, are to Blue Star Foods Corp., a Delaware corporation, and its consolidated subsidiaries, John Keeler & Co., Inc., d/b/a Blue Star Foods, a Florida corporation (“Keeler & Co.”), and its wholly-owned subsidiary, Coastal Pride Seafood, LLC, a Florida limited liability company (“Coastal Pride”), Taste of BC Aquafarms, Inc., a corporation formed under the laws of the Province of British Columbia, Canada (“TOBC”) and Afritex Ventures, Inc., a Florida corporation (“AFVFL”).

 

3

 

 

PART I – FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

The accompanying unaudited financial statements have been prepared in accordance with accounting principles generally accepted in the United States and the rules of the SEC, and should be read in conjunction with the audited financial statements and notes thereto contained in our Annual Report on Form 10-K for the year ended December 31, 2025. In the opinion of management, all adjustments, consisting of normal recurring adjustments, necessary for a fair presentation of financial position and the results of operations for the periods presented have been reflected herein. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year.

 

Blue Star Foods Corp. 

CONSOLIDATED BALANCE SHEETS

 

   MARCH 31, 2026   DECEMBER 31, 2025 
   Unaudited   Audited 
ASSETS          
CURRENT ASSETS          
Cash and cash equivalents  $16,948   $14,436 
Accounts receivable, net of allowances and credit losses of $25,141 and $24,117   93,425    55,091 
Inventory, net   355,572    404,979 
Other current assets   574,416    594,220 
Advance to related party   89,457    91,925 
Total Current Assets   1,129,818    1,160,651 
FIXED ASSETS, net   99,799    106,150 
RIGHT OF USE ASSET   40,383    50,097 
OTHER ASSETS   67,714    69,336 
TOTAL ASSETS  $1,337,714   $1,386,234 
LIABILITIES AND STOCKHOLDERS’ EQUITY          
CURRENT LIABILITIES          
Accounts payables  $903,887   $538,635 
Accrued expense   433,178   $355,283 
Accrued compensation   480,000    480,000 
Convertible notes, net of debt discounts   55,500    55,500 
Convertible notes, at fair value   1,980,230    1,822,102 
Current maturities of lease liabilities   39,924    39,577 
Loan payable, net of non current portion   363,919    364,254 
Other current liabilities   8,030    33,367 
Total Current Liabilities   4,264,668    3,688,718 
LONG-TERM LIABILITIES          
Lease liability, net of current portion   459    10,520 
Loan payable, net of current portion   40,998    43,498 
TOTAL LIABILITIES   4,306,125    3,742,736 
STOCKHOLDERS’ EQUITY          
Series A Super-Voting Convertible Preferred Stock, $0.0001 par value; 5,000,000 shares authorized, 1,550,000 shares issued and outstanding as of March 31, 2026, and 1,000,000 shares issued and outstanding as of December 31, 2025   155    100 
Common stock, $0.0001 par value, 5,000,000,000 shares authorized; 163,880,101 shares issued and outstanding as of March 31, 2026, and 91,631,955 shares issued and outstanding as of December 31, 2025   16,379    9,154 
Additional paid-in capital   47,785,182    47,649,570 
Accumulated other comprehensive loss   (86,604)   (67,171)
Accumulated deficit   (50,607,045)   (49,871,732)
Stock subscription receivable   (155)    (100) 
Treasury stock, 151 shares as of March 31, 2026 and 151 shares as of December 31, 2025   (76,323)   (76,323)
TOTAL STOCKHOLDERS’ EQUITY   (2,968,411)   (2,356,502)
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $1,337,714   $1,386,234 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

4

 

 

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

(UNAUDITED)

 

   2026   2025 
   Three Months Ended March 31 
   2026   2025 
         
REVENUE, NET  $250,259   $960,758 
           
COST OF REVENUE   241,512   869,114 
           
GROSS PROFIT   8,747    91,644 
           
SALARIES AND WAGES   182,877    270,284 
DIRECTOR COMPENSATION   138,012    138,012 
DEPRECIATION AND AMORTIZATION   6,386    6,386 
OTHER OPERATING EXPENSES   201,565    648,483 
           
LOSS FROM OPERATIONS   (520,093)   (971,521)
           
OTHER INCOME   1,280    6,615 
CHANGE IN FAIR VALUE OF DERIVATIVE AND WARRANT LIABILITIES   -    14,090 
CHANGE IN FAIR VALUE OF CONVERTIBLE NOTES   (136,729)   - 
LOSS ON SETTLEMENT OF DEBT   (47,241)   (41,066)
INTEREST EXPENSE   (32,530)   (208,048)
           
NET LOSS   (735,313)   (1,199,930)
           
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS  $(735,313)  $(1,199,930)
           
COMPREHENSIVE LOSS:          
           
CHANGE IN FOREIGN CURRENCY TRANSLATION ADJUSTMENT   (19,433)   18,840 
           
COMPREHENSIVE LOSS   (754,746)   (1,181,090)
Loss per common share:          
Net loss per common share - basic and diluted  $(0.00)  $(0.08)
Weighted average common shares outstanding - basic and diluted   145,307,833    14,452,810 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

5

 

 

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (DEFICIT) (UNAUDITED)

THREE MONTHS ENDED MARCH 31, 2026 AND 2025

 

   Shares   Amount   Shares   Amount  

Additional Paid-in

Capital

  

Accumulated

Deficit

  

Stock Subscription

Receivable

  

Accumulated Other

Comprehensive Income

(Loss)

   Treasury Stock  

Total Stockholders’

Equity

 
  

Series A Preferred Stock

$.0001 par value

  

Common Stock

$.0001 par value

                         
   Shares   Amount   Shares   Amount  

Additional Paid-in

Capital

  

Accumulated

Deficit

  

Stock Subscription

Receivable

  

Accumulated Other

Comprehensive Income

(Loss)

   Treasury Stock  

Total Stockholders’

Equity

 
December 31, 2025   1,000,000   $100    91,631,956   $9,154   $47,649,570   $(49,871,732)  $(100)  $(67,171)  $(76,323)  $(2,356,502)
Stock based compensation   -    -    -    -    3,012    -         -    -    3,012 
Common stock issued for service   -    -    4,085,714    409    32,591    -         -    -    33,000 
Common stock issued for note payment   -    -    68,162,431    6,816    100,009    -         -    -    106,825 
Series A Super-Voting Convertible Preferred Stock   550,000    55    -    -    -    -    (55)   -    -    - 
Net Loss   -    -    -    -    -    (735,313)        -    -    (735,313)
Cumulative translation adjustment   -    -    -    -    -    -         (19,433)   -    (19,433)
March 31, 2026   1,550,000   $155    163,880,101   $16,379   $47,785,182   $(50,607,045)  $(155)  $(86,604)  $(76,323)  $(2,968,411)

 

  

Series A Preferred Stock

$.0001 par value

  

Common Stock

$.0001 par value

                         
   Shares   Amount   Shares   Amount  

Additional Paid-in

Capital

   Accumulated
Deficit
  

Stock Subscription

Receivable

  

Accumulated Other

Comprehensive Income

(Loss)

   Treasury Stock  

Total

Stockholders’

Equity (Deficit)

 
December 31, 2024   -   $-    9,837,374   $974   $46,167,697   $(46,289,219)  $-   $5,174   $(76,323)  $(191,697)
Stock based compensation   -    -    -    -    (5,627)   -    -    -    -    (5,627)
Common stock issued for service   -    -    302,762    30    32,970    -    -    -    -    33,000 
Common stock issued for directors stock compensation             4,320,000    432    539,568         -              540,000 
Common stock issued for note payment   -    -    1,444,585    145    147,676    -    -    -    -    147,821 
Common stock issued for cash             350,000    35    19,915    -    -    -    -    19,950 
Net Loss   -    -    -    -    -    (1,199,930)   -    -    -    (1,199,930)
Cumulative translation adjustment   -    -    -    -    -    -    -    18,840    -    18,840 
March 31, 2025   -   $-    16,254,721   $1,616   $46,902,199   $(47,489,149)  $-   $24,014   $(76,323)  $(637,642)

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

6

 

 

Blue Star Foods Corp.

CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

 

   2026   2025 
   Three Months Ended March 31 
   2026   2025 
CASH FLOWS FROM OPERATING ACTIVITIES:          
           
Net Loss  $(735,313)  $(1,199,930)
Adjustments to reconcile net loss to net cash (used in) operating activities:          
Stock based compensation   3,012    (5,627)
Common stock issued for service   33,000    33,000 
Depreciation of fixed assets   6,386    6,386 
Amortization of debt discounts   7,500    94,009 
Allowance for inventory obsolescence   14,936   (18,378)
Loss on settlement of debt   47,241    40,166 
Lease expense   9,714    9,546 
Credit loss expense   710    (8,407)
Gain on revaluation of fair value of derivative and warrant liabilities   -    (14,090)
Loss on revaluation of fair value of convertible notes   136,729    - 
Changes in operating assets and liabilities:          
Accounts receivables   (39,045)   (97,469)
Inventories   34,471    123,313 
Advances to related parties   -    - 
Other current assets   22,270    176,682 
Right of use liability   (9,714)   (9,546)
Other assets   1,623    (20,000)
Accounts payable and accruals   308,147    531,184 
Accrued compensation   135,000    - 
Customer refunds   -    (33,389)
Other current liabilities   (25,337)   - 
Net Cash (Used in) Operating Activities   (48,670)   (392,550)
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
Purchases of fixed assets   -   (9,914)
Net Cash (Used in) Investing Activities   -   (9,914)
           
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from common stock offering   -    19,950 
Proceeds from short-term loan   -    550,000 
Proceeds from convertible debt   50,000    - 
Repayments of short-term loan   20,455   (489,783)
Net Cash Provided by Financing Activities   70,455    80,167 
           
Effect of Exchange Rate Changes on Cash   (19,273)   18,492 
           
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS   2,512    (303,805)
           
CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD   14,436    326,854 
           
CASH AND CASH EQUIVALENTS – END OF PERIOD  $16,948   $23,049 
           
Supplemental Disclosure of Cash Flow Information          
Cash paid for interest  $2,604   $25,472 
           
SUPPLEMENTAL DISCLOSURE OF NON-CASH ACTIVITIES          
Common stock issued for partial settlement of note payable   106,825    147,821 
Common stock issued for directors stock compensation   540,000    540,000 
Stock compensation reclassified to related party receivable   60,000    - 

 

The accompanying notes are an integral part of these unaudited consolidated financial statements

 

7

 

 

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

 

Note 1. Company Overview

 

Blue Star Foods Corp., a Delaware corporation (“we”, “our”, the “Company”), is an international sustainable marine protein company based in Miami, Florida that imports, packages and sells refrigerated pasteurized crab meat, and other premium seafood products. The Company’s main operating business, John Keeler & Co., Inc. (“Keeler & Co.”) was incorporated in the State of Florida in May 1995. The Company has three other subsidiaries, Coastal Pride, TOBC and AFVFL which maintain the Company’s fresh crab meat, steelhead salmon and packaged seafood and other inventory businesses, respectively. The Company’s current source of revenue is importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in

Canada.

 

On February 3, 2022, Coastal Pride entered into an asset purchase agreement with Gault Seafood, LLC, a South Carolina limited liability company (“Gault Seafood”), and Robert J. Gault II, President of Gault Seafood (“Gault”) pursuant to which Coastal Pride acquired all of the Seller’s right, title and interest in and to assets relating to Gault Seafood’s soft-shell crab operations, including intellectual property, equipment, vehicles and other assets used in connection with the soft-shell crab business. Coastal Pride did not assume any liabilities in connection with the acquisition. The purchase price for the assets consisted of a cash payment in the amount of $359,250 and the issuance of 8,355 shares of common stock of the Company with a fair value of $359,250. Such shares were subject to a leak-out agreement pursuant to which Gault Seafood could not sell or otherwise transfer the shares until February 3, 2023.

 

On February 1, 2024, the Company entered into a ninety-day Master Services Agreement (the “Services Agreement”) with Afritex Ventures, Inc. a Texas corporation (“Afritex”), pursuant to which the Company will be responsible for all of Afritex’s operations and finance functions. The Company will provide Afritex with working capital in order to sustain operations and will purchase certain inventory listed in the Services Agreement. In consideration for its services, during the term of the Services Agreement, the Company will earn all of the revenue and profits by the purchase and sale of Afritex’s inventory. Under the Services Agreement, Afritex may not sell or otherwise use as consideration any of its intellectual property without the Company’s consent. The Company must maintain certain commercial liability insurance during the term of the Services Agreement. The Services Agreement also provides that the Company may not solicit Afritex employees for 24 months nor circumvent existing business relationships of Afritex for three years, after the term of the Services Agreement. The term of the Services Agreement will automatically extend for three thirty-day periods, if Afritex’s outstanding debt is no greater than $325,000. The Company automatically extended the Service Agreement to August 31, 2024 after which it expired. The Company incurred losses of approximately $1.5 million from our Services Agreement with Afritex.

 

In connection with the Services Agreement, on February 12, 2024, the Company entered into an Intangibles Assets and Machinery Option to Purchase Agreement with Afritex (the “Option Agreement”). Pursuant to the Option Agreement, the Company has the option to purchase Afritex’s intangible assets, machinery and equipment set forth in the Option Agreement for a purchase price of $554,714 for machinery and equipment and 100,000 shares of the Company’s common stock were issued on February 12, 2024 to be held in escrow, for intangible assets. The Company did not exercise its option to purchase such intangible assets, machinery and equipment.

 

In connection with the Services Agreement, on February 1, 2024, AFVFL, a wholly-owned subsidiary of the Company, was incorporated in the State of Florida for the purpose of purchasing raw materials from Afritex for the preparation of packaged seafood and other inventory to be sold to various customers in the United States. Following the expiration of the Services Agreement with Afritex, AFVFL is no longer an active operating entity of the Company. AFVFL has not conducted any operating activities since the expiration of the Services Agreement and had no material assets or liabilities as of December 31, 2025.

 

During the year ended December 31, 2025, the Company dissolved Afritex Ventures Inc. (“AFVFL”).

 

8

 

 

On May 20, 2024, the Company amended its Certificate of Incorporation to affect a one-for-fifty reverse stock split (“Reverse Stock Split”), which became effective the same day. All share and per share amounts have been restated for all periods presented to reflect the Reverse Stock Split.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Presentation

 

The following unaudited interim consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, such interim financial statements do not include all the information and footnotes required by accounting principles generally accepted in the United States (“GAAP”) for complete annual financial statements. The information furnished reflects all adjustments, consisting only of normal recurring items which are, in the opinion of management, necessary in order to make the financial statements not misleading. The results of operations for the interim periods are not necessarily indicative of the results to be expected for the full year. The consolidated balance sheet as of December 31, 2025 has been derived from the Company’s annual financial statements that were audited by our independent registered public accounting firm but does not include all of the information and footnotes required for complete annual financial statements. These financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto which are included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on May 22, 2026 for a broader discussion of our business and the risks inherent in such business.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company, Keeler & Co, Inc. a wholly owned subsidiary, Coastal Pride Seafood, LLC (“Coastal Pride”), a wholly owned subsidiary of Keeler & Co., Inc., Taste of BC Aquafarms, Inc. (“TOBC”), a wholly owned subsidiary, and Afritex Ventures Inc. (“AFVFL”) a wholly owned subsidiary. AFVFL was dissolved during 2025 and, accordingly, its accounts are included in the consolidated financial statements only through the date of dissolution. All intercompany balances and transactions have been eliminated in consolidation.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers, as such, we record revenue when our customer obtains control of the promised goods or services in an amount that reflects the consideration which the Company expects to receive in exchange for those goods or services. The Company’s source of revenue is from importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in Canada. We sell primarily to food service distributors. The Company also sells its products to wholesalers, retail establishments and seafood distributors.

 

To determine revenue recognition for the arrangements that the Company determines are within the scope of Topic 606, the Company performs the following five steps: (1) identify the contract(s) with a customer by receipt of purchase orders and confirmations sent by the Company which includes a required line of credit approval process, (2) identify the performance obligations in the contract which includes shipment of goods to the customer FOB shipping point or destination, (3) determine the transaction price which initiates with the purchase order received from the customer and confirmation sent by the Company and will include discounts and allowances by customer if any, (4) allocate the transaction price to the performance obligations in the contract which is the shipment of the goods to the customer and transaction price determined in step 3 above and (5) recognize revenue when (or as) the entity satisfies a performance obligation which is when the Company transfers control of the goods to the customers by shipment or delivery of the products.

 

The Company elected an accounting policy to treat shipping and handling activities as fulfillment activities. Consideration payable to a customer is recorded as a reduction of the arrangement’s transaction price, thereby reducing the amount of revenue recognized, unless the payment is for distinct goods or services received from the customer.

 

Accounts Receivable

 

Accounts receivable consist of unsecured obligations due from customers under normal trade terms, usually net 30 days. The Company grants credit to its customers based on the Company’s evaluation of a particular customer’s credit worthiness.

 

Allowances for credit losses are maintained for potential credit losses based on the age of the accounts receivable and the results of the Company’s periodic credit evaluations of its customers’ financial condition. Receivables are written off as uncollectible and deducted from the allowance for doubtful accounts after collection efforts have been deemed to be unsuccessful. Subsequent recoveries are netted against the allowance for credit losses. The Company generally does not charge interest on receivables.

 

Receivables are net of estimated allowances for doubtful accounts and sales return, allowances and discounts. They are stated at estimated net realizable value. As of March 31, 2026, the Company recorded allowances for sales returns, allowances and discounts of approximately $25,100. There was no allowance for bad debt recorded for the three months ended March 31, 2026. As of December 31, 2025, the Company recorded sales return, allowances and discounts of approximately $24,100 and refund liability of $23,500. There was no allowance for bad debt recorded for the year ended December 31, 2025.

 

Inventories

 

Substantially all of the Company’s inventory consists of packaged crab meat located at a public cold storage facility and merchandise in transit from suppliers. The Company also has eggs and fish in process inventory from TOBC and raw materials for packaged seafood and other inventory from AFVFL. The cost of inventory is primarily determined using the specific identification method for crab meat and raw materials for packaged seafood inventory. Fish in process inventory is measured based on the estimated biomass of fish on hand. The Company has established a standard procedure to estimate the biomass of fish on hand using counting and sampling techniques. Inventory is valued at the lower of cost or net realizable value, cost being determined using the first-in, first-out method for crab meat and raw materials for packaged seafood inventory and using various estimates and assumptions in regard to the calculation of the biomass, including expected yield, market value of the biomass, and estimated costs of completion.

 

Merchandise is purchased on a cost and freight shipping point basis, and it becomes the Company’s asset and liability upon leaving the suppliers’ warehouse.

 

9

 

 

The Company periodically reviews the value of items in inventory and records an allowance to reduce the carrying value of inventory to the lower of cost or net realizable value based on its assessment of market conditions, inventory turnover and current stock levels. For the three months ended March 31, 2026, the Company recognized an inventory reserve of $69,155, resulting in an inventory allowance of $531,555. For the year ended December 31, 2025, the Company recorded an inventory allowance in the amount of $516,619 which was charged to cost of goods sold.

 

The Company’s inventory as of March 31, 2026 and December 31, 2025 consists of:

 

  

March 31,

2026

  

December 31,

2025

 
         
Inventory purchased for resale  $866,228   $873,475 
Feeds and eggs processed   -    27,224 
Raw materials for packaged seafood   20,899    20,899 
Less: Inventory allowance   (531,555)   (516,619)
Inventory, net  $355,572   $404,979 

 

Lease Accounting

 

The Company accounts for its leases under ASC 842, Leases, which requires all leases to be reported on the balance sheet as right-of-use assets and lease obligations. The Company elected the practical expedients permitted under the transition guidance that retained the lease classification and initial direct costs for any leases that existed prior to adoption of the standard.

 

The Company categorizes leases with contractual terms longer than twelve months as either operating or finance. Finance leases are generally those leases that would allow the Company to substantially utilize or pay for the entire asset over its estimated life. Assets acquired under finance leases are recorded in property and equipment, net. All other leases are categorized as operating leases. The Company did not have any finance leases as of March 31, 2026. The Company’s leases generally have terms that range from three years for equipment and six to seven years for real property. The Company elected the accounting policy to include both the lease and non-lease components of its agreements as a single component and accounts for them as a lease.

 

Lease liabilities are recognized at the present value of the fixed lease payments using a discount rate based on similarly secured borrowings available to us. Lease assets are recognized based on the initial present value of the fixed lease payments, reduced by landlord incentives, plus any direct costs from executing the lease. Lease assets are tested for impairment in the same manner as long-lived assets used in operations. Leasehold improvements are capitalized at cost and amortized over the lesser of their expected useful life or the lease term.

 

When we have the option to extend the lease term, terminate the lease before the contractual expiration date, or purchase the leased asset, and it is reasonably certain that we will exercise the option, we consider these options in determining the classification and measurement of the lease. Costs associated with operating lease assets are recognized on a straight-line basis within operating expenses over the term of the lease.

 

10

 

 

Long-lived Assets

 

Management reviews long-lived assets, including finite-lived intangible assets, for indicators of impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. Cash flows expected to be generated by the related assets are estimated over the asset’s useful life on an undiscounted basis. If the evaluation indicates that the carrying value of the asset may not be recoverable, the potential impairment is measured using fair value. Fair value estimates are completed using a discounted cash flow analysis. Impairment losses for assets to be disposed of, if any, are based on the estimated proceeds to be received, less costs of disposal. No impairment was recognized for the three months ended March 31, 2026 and for the year ended December 31, 2025.

 

Foreign Currency Exchange Rates Risk

 

The Company manages its exposure to fluctuations in foreign currency exchange rates through its normal operating activities. Its primary focus is to monitor exposure to, and manage, the economic foreign currency exchange risks faced by, its operations and realized when the Company exchanges one currency for another. The Company’s operations primarily utilize the U.S. dollar and Canadian dollar as its functional currencies. Movements in foreign currency exchange rates affect its financial statements.

 

Fair Value Measurements and Financial Instruments

 

Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date and is measured using inputs in one of the following three categories:

 

Level 1 measurements are based on unadjusted quoted prices in active markets for identical assets or liabilities that we have the ability to access. Valuation of these items does not entail a significant amount of judgment.

 

Level 2 measurements are based on quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active or market data other than quoted prices that are observable for the assets or liabilities.

 

Level 3 measurements are based on unobservable data that are supported by little or no market activity and are significant to the fair value of the assets or liabilities.

 

The Company’s financial instruments include cash, accounts receivable, accounts payable, accrued expenses, debt obligations, derivative liabilities and warrant liabilities. The Company believes the carrying values of cash, accounts receivable, accounts payable and accrued expenses approximate their fair values because they are short term in nature or payable on demand. The Company elected to account for certain convertible promissory notes at fair value, with the entire instrument measured at fair value on a recurring basis rather than separately accounting for embedded conversion features. The Company had convertible debt measured at fair value as of March 31, 2026 and December 31, 2025.

 

  

As of

March 31, 2026

  

As of

December 31, 2025

 
   Level 3 Fair Value 
  

As of

March 31, 2026

  

As of

December 31, 2025

 
Liabilities        
Fair value of convertible debt  $1,980,230   $1,822,102 
Total  $1,980,230   $1,822,102 

 

11

 

 

The table below presents the change in the fair value of the convertible note payable for the three months ended March 31, 2026 and year ended December 31, 2025:

 

  

March 31,

2026

  

December 31,

2025

 
         
Fair value balance, beginning of year  $1,822,102   $- 
Issuance of convertible note payable   21,399    499,063 
Change in fair value   136,729    1,323,039 
Fair value balance, end of year  $1,980,230   $1,822,102 

 

The fair market value of all convertible debt as of December 31, 2025 was determined using the Monte Carlo simulation model which used the following assumptions:

  

Stock price  $0.0018 
Expected dividend yield   0.00%
Expected stock price volatility   230.50250.36%
Risk-free interest rate   3.48%
Expected term   0.481.04 years 

 

The fair market value of all convertible debt as of March 31, 2026 was determined using the Monte Carlo simulation model which used the following assumptions:

 

Stock price  $0.001 
Expected dividend yield   0.00%
Expected stock price volatility   250.18%
Risk-free interest rate   3.68%
Expected term   0.22 0.79 years 

 

Segment Information

 

The Company’s business consists of one operating segment, which is also its one reportable segment. The Company derives revenue by providing sales of primarily seafood products to customers. The Company’s CODM is its chief executive officer who reviews financial information presented on a consolidated basis. The CODM reviews total assets in the consolidated balance sheets and net loss and its components in the consolidated statement of operations such as, cost of goods sold and other operating expenses, to assess financial performance and allocate resources.

 

Recent Accounting Pronouncements

 

ASU 2023-09 – Income Taxes (Topic 740)

 

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This ASU aims to enhance the transparency and usefulness of income tax disclosures by requiring public business entities to provide more disaggregated information in the effective tax rate reconciliation and for income taxes paid. Key provisions include a requirement for tabular reconciliation using both percentages and amounts, broken out into specific categories, with certain reconciling items at or above a 5% quantitative threshold further disaggregated by nature and/or jurisdiction. Additionally, the ASU requires disclosure of income taxes paid (net of refunds received), disaggregated by federal, state/local, and foreign jurisdictions, and amounts paid to individual jurisdictions that comprise 5% or more of total income taxes paid. The ASU also eliminates certain existing disclosure requirements related to unrecognized tax benefits and cumulative unrecognized deferred tax liabilities. For public business entities, the amendments in ASU 2023-09 are effective for annual periods beginning after December 15, 2024. The Company adopted ASU 2023-09 effective January 1, 2025. The adoption of this guidance did not have a material impact on the Company’s consolidated financial statements.

 

12

 

 

ASU 2024-03 – Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40): Disaggregation of Income Statement Expenses. This ASU requires public business entities to disclose more detailed information about certain costs and expenses in the notes to their financial statements, both in annual and interim filings. The objective is to provide investors with greater transparency into a company’s expense structure, enabling a better understanding of performance, assessment of future cash flows, and comparison with other entities. Key provisions include the disaggregation, in a tabular format, of specific natural expense categories such as purchases of inventory, employee compensation, depreciation, and intangible asset amortization, within each relevant expense caption on the income statement. The ASU also requires disclosure of the total amount of selling expenses and a qualitative description of expenses remaining in the “other” category. For public business entities, the amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. The Company is currently evaluating the impact of adopting this ASU on its financial statements and disclosures.

 

ASU 2025-11 — Interim Reporting (Topic 270)

 

In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270). This ASU enhances interim reporting requirements by improving the consistency and transparency of disclosures provided in interim financial statements. The amendments are designed to provide users with more decision-useful information about changes in financial position and results of operations during interim periods. For public business entities, the amendments are effective for interim reporting periods beginning after December 15, 2025. The Company is currently evaluating the impact of adopting this ASU on its interim financial statement disclosures.

 

ASU 2025-12 — Accounting Standards Codification Improvements

 

In December 2025, the FASB issued ASU 2025-12, Accounting Standards Codification Improvements. This ASU includes various amendments to the Accounting Standards Codification intended to clarify, correct, or improve existing guidance. The amendments generally do not change current accounting practice and are not expected to have a material impact on the Company’s financial statements. For public business entities, the amendments are

 

Note 3. Going Concern

 

The accompanying consolidated financial statements and notes have been prepared assuming the Company will continue as a going concern. For the three months ended March 31, 2026, the Company incurred a net loss of $735,313, had an accumulated deficit of $50,607,045 and a working capital deficit of $3,134,850. These factors raise substantial doubt as to the Company’s ability to continue as a going concern. The Company’s ability to continue as a going concern is dependent upon the Company’s ability to increase revenues, execute on its business plan to acquire complimentary companies, raise capital, and to continue to sustain adequate working capital to finance its operations. The failure to achieve the necessary levels of profitability and cash flows would be detrimental to the Company. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

Note 4. Other Current Assets

 

Other current assets totaled $574,416 as of March 31, 2026 and $594,220 as of December 31, 2025. As of March 31, 2026 and December 31, 2025, approximately $501,000 and $26,000 of the balance was related to prepaid inventory to the Company’s suppliers and professional fees, respectively. The remainder of the balance was related to prepaid insurance and other prepaid expenses.

 

Note 5. Fixed Assets, Net

 

Fixed assets comprised the following:

 

  

March 31,

2026

  

December 31,

2025

 
Computer equipment  $56,746   $56,746 
RAS system   7,468    7,433 
Automobiles   94,298    94,298 
Leasehold improvements   17,904    17,904 
Total   176,416    176,381 
           
Less: Accumulated depreciation   (76,617)   (70,231)
Fixed assets, net  $99,799   $106,150 

 

For the three months ended March 31, 2026 and 2025, depreciation expense totaled approximately $6,400.

 

13

 

 

Note 6. Loans, Convertible Debt, and Derivative Liabilities

 

Lind Global Fund II LP notes

 

2023 Note

 

On May 30, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with Lind pursuant to which the Company issued to Lind a secured, two-year, interest free convertible promissory note in the principal amount of $1,200,000 (the “2023 Lind Note”) and a warrant (the “Lind Warrant”) to purchase 8,701 shares of common stock of the Company commencing six months after issuance and exercisable for five years at an exercise price of $122.50 per share. The Lind Warrant includes cashless exercise and full ratchet anti-dilution provisions. In connection with the issuance of the Lind Note and the Lind Warrant, the Company paid Lind a $50,000 commitment fee. The proceeds from the sale of the Note and Warrant are for general working capital purposes.

 

In connection with the issuance of the 2022 Lind Note, the Company and Lind amended the 2022 Security Agreement to include the new 2023 Lind Note, pursuant to an amended and restated security agreement, dated May 30, 2023, between the Company and Lind.

 

The Company agreed to file a registration statement with the Securities and Exchange Commission covering the resale of the shares of common stock issuable pursuant to the 2023 Lind Note and Lind Warrant. Lind was also granted piggyback registration rights.

 

If the Company engages in capital raising transactions, Lind has the right to purchase up to 20% of the new securities for 24 months.

 

The 2023 Lind Note is convertible into common stock of the Company after the earlier of 90 days from issuance or the date the registration statement is effective, provided that no such conversion may be made that would result in beneficial ownership by Lind and its affiliates of more than 4.99% of the Company’s outstanding shares of common stock. The conversion price of the 2023 Lind Note is equal to the lesser of: (i) $120.00; or (ii) 90% of the lowest single volume-weighted average price during the twenty-trading day period ending on the last trading day immediately preceding the applicable conversion date, subject to customary adjustments. The maximum number of shares of common stock to be issued in connection with the conversion of the 2023 Lind Note and the exercise of the Lind Warrant, in the aggregate, will not, exceed 19.9% of the outstanding shares of common stock of the Company immediately prior to the date of the 2023 Lind Note, in accordance with NASDAQ rules and guidance. Due to the variable conversion price of the 2023 Lind Note, the embedded conversion feature was accounted as a derivative liability. The fair value of the derivative liability at issuance amounting to $264,687, was recorded as a debt discount and amortized over the term of the note.

 

The 2023 Lind Note contains certain negative covenants, including restricting the Company from certain distributions, stock repurchases, borrowing, sale of assets, loans and exchange offers.

 

Upon the occurrence of an event of default as described in the 2023 Lind Note, the 2023 Lind Note will become immediately due and payable at a default interest rate of 120% of the then outstanding principal amount of the Lind Note.

 

The Warrant entitles the Investor to purchase up to 8,701 shares of common stock of the Company during the exercise period commencing on the date that is six months after the issue date (“Exercise Period Commencement”) and ending on the date that is sixty months from the Exercise Period Commencement at an exercise price of $122.50 per share, subject to customary adjustments. The Warrant includes cashless exercise and full ratchet anti-dilution provisions.

 

On July 27, 2023, the Company, entered into a First Amendment to the Purchase Agreement (the “Purchase Agreement Amendment”) with Lind, which provided for the issuance of further senior convertible promissory notes up to an aggregate principal amount of up to $1,800,000 and the issuance of additional warrants in such amounts as the Company and Lind shall mutually agree.

 

Pursuant to the Purchase Agreement Amendment, the Company issued to Lind a two-year, interest free convertible promissory note in the principal amount of $300,000 and a warrant to purchase 3,505 shares of common stock of the Company at an exercise price of $67.00 per share for $250,000. In connection with the issuance of the note and the warrant, the Company paid a $12,500 commitment fee. The proceeds from the sale of the note and warrant are for general working capital purposes.

 

Due to the variable conversion price of the convertible promissory note, pursuant to the Purchase Agreement Amendment, the embedded conversion feature was accounted for as a derivative liability. The fair value of the derivative liability at issuance amounting to $118,984, was recorded as a debt discount and amortized over the term of the note.

 

On August 3, 2024 the Company and Lind entered into a waiver and acknowledgement agreement.

 

The Company and Lind previously entered into that certain Securities Purchase Agreement, dated as of May 20, 2023, as amended on July 27, 2023 pursuant to which the Company issued Lind a senior convertible promissory note in the principal amount of $300,000. Each of the Company and Lind acknowledge that the amounts owing under the convertible promissory note as of the filing of the Waiver Agreement is equal to $355,500.

 

During the three months ended March 31, 2026, there were no payments to the note principal. As of March 31, 2026 and December 31, 2025, the outstanding balance on the notes was $55,500. As of March 31, 2026 and December 31, 2025, there was no derivative liability and warrant liability.

 

Debt with Third-Party Investors

 

On January 28, 2025, the Company entered into a subordinated business loan and security agreement with a third-party lender and collateral agent providing for a term loan in the principal amount of $420,000, with total repayment of principal and interest of $596,400 and a maturity date of August 15, 2025. Commencing February 7, 2025, the Company is required to make weekly payments of $21,300 until the maturity date. The loan may be prepaid subject to a prepayment fee. In connection with the loan, the Company paid an administrative agent fee of $20,000, which was recorded as a debt discount and is being amortized over the term of the loan. For the three months ended March 31, 2026, the Company made no principal and interest payments. The outstanding balance on the loan was $266,000 as of March 31, 2026.

 

15

 

 

On January 28, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $149,650 with an original issue discount of $19,650 (the “January 2025 Convertible Note”). The January 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $19,454 paid upon issuance and a maturity date of October 30, 2025. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the January 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the January 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the January 2025 Convertible Note. For the three months ended March 31, 2026, the Company made principal payments on the loan totaling $6,860 and no interest payments. The outstanding balance of on the loan was $53,312 as of March 31, 2026, compared to $60,172 as of December 31, 2025.

 

On August 25, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $169,500 with an original issue discount of $25,425 (the “August 2025 Convertible Note”). The August Convertible Note has an interest rate of 13% with a one-time interest payment of $22,035 paid upon issuance and a maturity date of August 25, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the August Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the August Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the August Convertible Note. For the three months ended March 31, 2026, the Company made no principal payments and interest payments of $8,628. The outstanding balance of on the note was $169,500 as of March 31, 2026 and December 31, 2025. Interest expense related to the loan $14,137 for the three months ended March 31, 2026.

 

On December 5, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $73,025 with an original issue discount of $9,525 (the “December 2025 Convertible Note”). The December 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $9,493 paid upon issuance and a maturity date of December 5, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the December 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the December 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the December 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance of on the note was $73,025 as of March 31, 2026 and December 31, 2025.

 

On September 16, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $47,059 with an original issue discount of $7,059 (the “September 16, 2025 Convertible Note”). The September 16, 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $6,118 paid upon issuance and a maturity date of June 16, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the September 16, 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the September 16, 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September 16, 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $47,059 as of March 31, 2026 and December 31, 2025. Interest expense related to the loan $2,039 for the three months ended March 31, 2026.

 

On November 13, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $40,000 with an original issue discount of $6,000 (the “November 2025 Convertible Note”). The November 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $5,200 paid upon issuance and a maturity date of August 13, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the November 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the November 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the November 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $40,000 as of March 31, 2026 and December 31, 2025. Interest expense related to the loan $1,733 for the three months ended March 31, 2026.

 

On September 18, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $47,059 with an original issue discount of $7,059 (the “September 18, 2025 Convertible Note”). The September 18, 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $6,118 paid upon issuance and a maturity date of June 16, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the September 18, 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the September 18, 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September 18, 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $47,059 as of March 31, 2026 and December 31, 2025. Interest expense related to the loan $2,039 for the three months ended March 31, 2026.

 

16

 

 

On March 10, 2026, the Company issued a convertible promissory note to a third-party investor in the principal amount of $57,500 (the “March 2026 Convertible Note”). The note was issued with an original issue discount of $7,500, resulting in net proceeds to the Company of $50,000. The note includes a one-time interest charge of $7,475 and has a maturity date of December 10, 2026. Upon the occurrence of an event of default, the note accrues interest at a rate of up to 24% per annum on the outstanding principal balance. The note may be prepaid in accordance with its terms and may also be convertible into shares of the Company’s common stock, subject to the provisions of the note agreement. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $57,500.

 

August 2024 Private Placement Offering

 

In August, 2024, the Company entered into securities purchase agreements (each a “Securities Purchase Agreement”) with each of Quick Capital, LLC, a Wyoming limited liability company (“Quick Capital”) and Jefferson Street Capital, LLC, a New Jersey limited liability company (“Jefferson”) whereby we issued promissory notes in the aggregate principal amount of $550,000 (the “August Private Placement Offering”).

 

The Company agreed to issue to Quick Capital and Jefferson up to 39,300 shares of our Common Stock as a “Commitment Fee”.

 

As part of the August Private Placement Offering, the Company issued two promissory notes each in the principal amount of $275,000 with an original issue discount of $25,000 (the “Private Placement Notes”). The Private Placement Notes have a one-time interest payment of $27,500. Thereafter, any principal amount of interest which is not paid upon maturity will accrue at a rate of the lesser of (i) sixteen percent (16%) per annum, or (ii) the maximum amount permitted by law from the due date thereof until the same is paid. The Private Placement Notes have a maturity date of 10 months after issuance and the proceeds from the notes are for general corporate purposes. The Company agreed to issue to each of Quick Capital and Jefferson 19,650 shares of Common Stock as additional consideration for entering into Private Placement Notes.

 

The investors have the right, at any time on or following the earlier of (i) the date that any of the shares are registered for resale under a registration statement of the Company or (ii) the date that is six (6) months after the issue date, to convert all or any portion of the then outstanding and unpaid principal and interest into fully paid and non-assessable shares of our Common Stock. The conversion price shall be $1.50, subject to adjustments. We have agreed to reserve a sufficient number of Common Stock (initially, 2,000,000 shares) for issuance upon conversion of the Private Placement Notes in accordance with their terms.

 

If an event of default occurs under the Private Placement Notes, the investors have the right to convert all amounts outstanding under the notes at any time thereafter into shares of Common Stock at the lesser of (i) the then applicable conversion price under the notes or (ii) the Market Price. “Market Price” shall mean 85% of the lowest VWAP on any trading day during the ten (10) trading days prior to the respective conversion date. “VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the principal market during the period beginning at 9:30 a.m., Eastern Standard Time, and ending at 4:00 p.m., Eastern Standard Time, as reported by Quote stream or other similar quotation service provider designated by the investors.

 

The Company may prepay the Private Placement Notes at any time with fifteen (15) trading days prior written notice (the “Prepayment Notice Period”). During the Prepayment Notice Period, the investor shall have the right to convert all or any portion of the Private Placement Notes pursuant to the terms of the notes, including the amount of the Private Placement Notes to be prepaid. If the Company exercises its right to prepay the notes, the Company shall make payment to the investor of an amount in cash equal to the sum of: (i) 100% multiplied by the principal amount then outstanding plus (ii) accrued and unpaid interest on the principal amount to the Prepayment Notice Date, and (iii) $750 to reimburse the investor for administrative fees.

 

17

 

 

If the Company delivers a prepayment notice and fails to pay the applicable prepayment amount, the Company shall forever forfeit its right to prepay any part of the Private Placement Notes.

 

The Private Placement Notes have mandatory monthly payments of $43,200. The initial payments are due on November 9, 2024 and November 12, 2024, respectively.

 

The Company’s failure to comply with the material terms of the Private Placement Notes will be considered an event of default and the principal sum of the Private Placement Notes will become immediately due and payable at an amount equal to the principal amount then outstanding plus accrued interest (including any default interest) through the date of full repayment multiplied by 135%, as well as all costs, all without demand, presentment or notice, unless expressly waived by the investor.

 

The investors may assign their rights to any “accredited investor” (as defined in Rule 501(a) of the 1933 Act) in a private transaction or to any of its affiliates without the consent of the Company.

 

While the Private Placement Notes remain outstanding, we shall not, without the investor’s written consent (i) (a) pay, declare or set apart for such payment, any dividend or other distribution on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution with respect to its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Company’s disinterested directors, (ii) redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Company or any warrants, rights or options to purchase or acquire any such shares, or repay any indebtedness of the investor (iii) advance any loans made in the ordinary course of business in excess of $100,000, (iv) sell, lease or otherwise dispose of any significant portion of our assets outside the ordinary course of business, and (v) enter into any transaction or arrangement structured in accordance with, based upon, or related or pursuant to, in whole or in part, either Section 3(a)(9) or Section 3(a)(10) of the Securities Act.

 

In conjunction with the August Private Placement Offering, the Company entered into a registration rights agreement with each of Quick Capital and Jefferson. The Company agreed to file a registration statement with the Securities and Exchange Commission to register the re-sale of the maximum number of shares of Common Stock covered in the August Private Placement Offering within sixty (60) calendar days from the date of execution.

 

During the three months ended March 31, 2026, the Company made aggregate principal payments on the Private Placement Notes of $29,242 of which was paid through the issuance of an aggregate of 43,152,282 shares of common stock. The outstanding balance on the loan was $33,006 as of March 31, 2026, compared to $62,249 as of December 31, 2025.

 

Unaffiliated Note

 

On October 29, 2025, the Company entered into a promissory note agreement with an unaffiliated third-party lender for aggregate principal of $50,000. The note bears interest at a rate of 32% per annum and matures on July 29, 2026. The proceeds are for general working capital. Upon the occurrence of an event of default as described in the note, the note will become immediately due and payable at a default interest rate of 25% of the then outstanding principal amount of the note. For the three months ended March 31, 2026, the Company made principal payments of $500 and no interest payments. The outstanding balance on the note was $41,419 as of March 31, 2026, compared to $41,919 as of December 31, 2025.

 

Vehicle Loan

 

On December 7, 2024, the Company entered into a financing loan in connection with the purchase of a company vehicle. The loan has a principal amount of $69,299, bears interest at an annual rate of 9.34%, and is repayable in monthly installments of $1,450, including principal and interest, over a term of 60 months. For the three months ended March 31, 2026, the Company made no principal payments on the loan and interest payments of $1,222. The outstanding balance on the loan was $56,185 as of March 31, 2026, compared to $56,185 as of December 31, 2025.

 

18

 

 

Note 7. Stockholders’ Equity

 

On March 11, 2025, the Company issued 350,000 shares of common stock in consideration of proceeds of $19,950 pursuant to a securities purchase agreement, dated May 16, 2023 with ClearThink.

 

On March 12, 2025, the Company issued 288,101 shares of common stock to Diagonal as partial conversion of $15,000 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2025, the Company issued an aggregate of 750,000 shares of common stock to Quick Capital as partial conversion of $57,673 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2025, the Company issued an aggregate of 406,484 shares of common stock to Jefferson as partial conversion of $32,583 principal and accrued interest pursuant to the convertible promissory note.

 

On January 16, 2026, the Company issued an aggregate of 4,085,714 shares of common stock, to the designee of ClearThink Capital for consulting services provided to the Company.

 

On January 27, 2026, the Company issued 550,000 shares of Series A Preferred with par value $0.0001 per share. The Series A Preferred was issued for no cash or other consideration and solely to establish a voting control structure. Each share of Series A Preferred entitles the holder to 100 votes per share on all matters submitted to a vote of the stockholders.

 

On January 28, 2026, the Company amended its Certificate of Incorporation to increase its authorized shares of common stock from 500,000,000 shares to 5,000,000,000 shares. The amendment was approved by the Company’s Board of Directors and stockholders in accordance with applicable law and became effective upon filing with the Secretary of State of the State of Delaware.

 

During the three months ended March 31, 2026, the Company issued an aggregate of 43,152,282 shares of common stock to Quick Capital as partial conversion of $29,242 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2026, the Company issued 9,910,149 shares of common stock to Diagonal as partial conversion of $6,860 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2026, the Company issued an aggregate of 15,100,000 shares of common stock to Labrys Fund as conversion of $8,627 interest pursuant to the convertible promissory note.

 

19

 

 

Note 8. Options

 

The following table represents option activity for the three months ended March 31, 2026:

 

  

Number

of Options

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life in

Years

  

Aggregate

Intrinsic

Value

 
Outstanding – December 31, 2025   3,385   $2,000.00    2.81     
Exercisable – December 31, 2025   3,352   $2,000.00    2.82   $- 
Granted   -   $-          
Forfeited   (30)  $-           
Vested   3,322   $  -                
Outstanding – March 31, 2026   3,355   $2,000.00    2.56      
Exercisable – March 31, 2026   3,322   $2,000.00    2.57   $- 

 

Note 9. Warrants

 

The following table represents warrant activity for the three months ended March 31, 2026:

 

  

Number

of Warrants

  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Life in

Years

  

Aggregate

Intrinsic

Value

 
Outstanding – December 31, 2025   13,423,969   $0.11    4.76      
Exercisable – December 31, 2025   13,423,969   $0.11    4.76   $- 
Granted   57,500,000   $-           
Exercised   -   $-           
Forfeited or Expired   -   $-           
Outstanding – March 31, 2026   70,923,969   $0.02    4.86      
Exercisable – March 31, 2026   70,923,969   $0.02    4.86   $- 

 

On May 30, 2023, in connection with the issuance of the $1,200,000 promissory note to Lind pursuant to a securities purchase agreement, the Company issued Lind a five-year warrant exercisable six months from the date of issuance to purchase 8,701 shares of common stock at an exercise price of $122.50 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $381,538 was recorded as a discount to the 2023 Lind Note and classified as liabilities.

 

On July 27, 2023, in connection with the issuance of the $300,000 promissory note to Lind pursuant to the Purchase Agreement Amendment, the Company issued Lind a five-year warrant exercisable six months from the date of issuance to purchase 3,505 shares of common stock at an exercise price of $67.00 per share. The warrant provides for cashless exercise and full ratchet anti-dilution provisions. The fair value of the warrants of $72,208 was recorded as a discount to the 2023 Purchase Agreement Amendment and classified as a liability.

 

On September 16, 2025, in connection with the issuance of the $47,059 promissory note to a third-party investor, the Company issued a five-year warrant exercisable from the date of issuance to purchase 4,705,882, shares of common stock at an exercise price of $0.01 per share. The warrant was determined to be equity-classified under applicable accounting guidance. No value was allocated to the warrant at issuance, as its fair value was determined to be immaterial.

 

On September 18, 2025, in connection with the issuance of the $47,059 promissory note to a third-party investor, the Company issued a five-year warrant exercisable from the date of issuance to purchase 4,705,882, shares of common stock at an exercise price of $0.01 per share. The warrant was determined to be equity-classified under applicable accounting guidance. No value was allocated to the warrant at issuance, as its fair value was determined to be immaterial.

 

On November 13, 2025, in connection with the issuance of the $40,000 promissory note to a third-party investor, the Company issued a five-year warrant exercisable from the date of issuance to purchase 4,000,000, shares of common stock at an exercise price of $0.01 per share. The warrant was determined to be equity-classified under applicable accounting guidance. No value was allocated to the warrant at issuance, as its fair value was determined to be immaterial.

 

On March 10, 2026, in connection with the issuance of the $57,500 promissory note to a third-party investor, the Company issued a five-year warrant exercisable from the date of issuance to purchase 57,500,000, shares of common stock at an exercise price of $0.001 per share. The warrant was determined to be equity-classified under applicable accounting guidance. No value was allocated to the warrant at issuance, as its fair value was determined to be immaterial.

 

20

 

 

Note 10. Commitment and Contingencies

 

Office lease

 

On January 1, 2022, the Company entered into a verbal month-to-month lease agreement for its executive offices with an unrelated third party and paid $13,800 on the lease for the three months ended March 31, 2025. For the three months ended March 31, 2026, the Company paid $4,500 under this lease.

 

The offices and facility of TOBC are located in Nanaimo, British Columbia, Canada and are on land which was leased to TOBC for approximately $2,500 per month plus taxes, from Steve and Janet Atkinson, a related party and the former TOBC owners. On April 1, 2022, TOBC entered into a new five-year lease with Steve and Janet Atkinson for CAD$2,590 per month plus taxes, and an additional five-year lease with Kathryn Atkinson for CAD$2,370 per month plus taxes. Both leases are renewable for two additional five-year terms.

 

On March 4, 2026, the Company, through its subsidiary TOBC, filed an application with the Supreme Court of British Columbia seeking to set aside a February 23, 2026 order that terminated its lease and granted possession of the leased property to the landlords. The Company is seeking relief, including reinstatement of the lease, and contends that certain relevant facts were not presented to the Court at the original hearing. A hearing on the application was held on March 9, 2026, and the Court has reserved judgment.

 

On June 2, 2026, the Supreme Court of British Columbia dismissed the application filed by the Company’s subsidiary, TOBC, seeking reconsideration of the Court’s February 23, 2026 order terminating TOBC’s commercial lease and granting possession of the leased aquaculture facility to the landlords.

 

On June 24, 2026, TOBC filed a Notice of Appeal with the Court of Appeal for British Columbia seeking to overturn the June 2, 2026 judgment. Among other grounds, the appeal contends that the Supreme Court failed to address provisions of the parties’ lease agreement, including Paragraph 39(f), which the Company believes prohibited either party from commencing legal proceedings while the parties were engaged in the contractual mediation process. The Company contends that, at the time the landlords commenced their petition seeking termination of the lease, the parties were already participating in mediation pursuant to the lease agreement and that this contractual provision was neither presented to nor considered by the Court in rendering its decision. The Company further notes that, in its June 2, 2026 Reasons for Judgment, the Court acknowledged that TOBC’s January 2026 rent payment was made within the lease’s contractual grace period.

 

The appeal seeks, among other relief, an order setting aside the June 2, 2026 judgment and remitting the matter to the Supreme Court of British Columbia for a new hearing on the reconsideration application.

 

The appeal is in its preliminary stages, and no hearing date has been scheduled. The Company intends to pursue all available legal remedies. Because appellate proceedings are inherently uncertain, there can be no assurance that the appeal will be successful. Accordingly, the Company cannot predict the ultimate outcome of the appeal or reasonably estimate any potential loss, if any, related to this litigation.

 

Rental and equipment lease expenses were approximately $3,900 for related party and $4,500 for non-related party for the three months ended March 31, 2026. For the three months ended March 31, 2025, rental lease expenses was approximately $11,400 for related party and $16,500 for non-related party.

 

Note 11. Reverse Stock Split

 

On January 28, 2026, the Board of Directors approved a reverse split of the Company’s issued and outstanding common stock at a ratio of not less than one-for-one hundred (1:100) and not greater than one-for-ten thousand (1:10,000). The Company’s stockholders approved the reverse stock split on January 28, 2026.

 

As of March 31, 2026, the reverse stock split has not become effective. The Company has not yet filed the Certificate of Amendment with the Secretary of State of the State of Delaware, and no effective date has been established. Accordingly, the accompanying consolidated financial statements do not reflect the effects of the proposed reverse stock split.

 

Note 12. Subsequent Events

 

British Columbia Lawsuit

 

On June 2, 2026, the Supreme Court of British Columbia dismissed the application filed by the Company’s subsidiary, TOBC, seeking reconsideration of the Court’s February 23, 2026 order terminating TOBC’s commercial lease and granting possession of the leased aquaculture facility to the landlords.

 

On June 24, 2026, TOBC filed a Notice of Appeal with the Court of Appeal for British Columbia seeking to overturn the June 2, 2026 judgment. Among other grounds, the appeal contends that the Supreme Court failed to address provisions of the parties’ lease agreement, including Paragraph 39(f), which the Company believes prohibited either party from commencing legal proceedings while the parties were engaged in the contractual mediation process. The Company contends that, at the time the landlords commenced their petition seeking termination of the lease, the parties were already participating in mediation pursuant to the lease agreement and that this contractual provision was neither presented to nor considered by the Court in rendering its decision. The Company further notes that, in its June 2, 2026 Reasons for Judgment, the Court acknowledged that TOBC’s January 2026 rent payment was made within the lease’s contractual grace period.

 

The appeal seeks, among other relief, an order setting aside the June 2, 2026 judgment and remitting the matter to the Supreme Court of British Columbia for a new hearing on the reconsideration application.

 

The appeal is in its preliminary stages, and no hearing date has been scheduled. The Company intends to pursue all available legal remedies. Because appellate proceedings are inherently uncertain, there can be no assurance that the appeal will be successful. Accordingly, the Company cannot predict the ultimate outcome of the appeal or reasonably estimate any potential loss, if any, related to this litigation.

 

21

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The following management’s discussion and analysis should be read in conjunction with the financial statements and the related notes thereto contained in this Quarterly Report. The management’s discussion and analysis contain forward-looking statements, such as statements of our plans, objectives, expectations and intentions. Any statements that are not statements of historical fact are forward-looking statements. When used, the words “believe,” “plan,” “intend,” “anticipate,” “target,” “estimate,” “expect” and the like, and/or future tense or conditional constructions (“will,” “may,” “could,” “should,” etc.), or similar expressions, identify certain of these forward-looking statements. These forward-looking statements are subject to risks and uncertainties, including those under “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the SEC on May 22, 2026, as updated in subsequent filings we have made with the SEC that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. Our actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of several factors. We do not undertake any obligation to update forward-looking statements to reflect events or circumstances occurring after the date of this Quarterly Report.

 

Basis of Presentation

 

The following discussion highlights our results of operations and the principal factors that have affected our financial condition as well as our liquidity and capital resources for the periods described and provides information that management believes is relevant for an assessment and understanding of the statements of financial condition and results of operations presented herein. The following discussion and analysis are based on our unaudited financial statements contained in this Quarterly Report, which we have prepared in accordance with United States generally accepted accounting principles. You should read the discussion and analysis together with such financial statements and the related notes thereto.

 

Overview

 

We are an international seafood company that imports, packages and sells refrigerated pasteurized crab meat, and other premium seafood products. Our current source of revenue is from importing blue and red swimming crab meat primarily from South East Asia and distributing it in the United States and Canada under several brand names such as Blue Star, Oceanica, Pacifika, Crab & Go, First Choice, Good Stuff and Coastal Pride Fresh, as well as soft shell crab in the United States and steelhead salmon and rainbow trout fingerlings produced under the brand name Little Cedar Farms for distribution in Canada. The crab meat which we import is processed in six out of the ten plants available throughout Southeast Asia. Our suppliers are primarily via co-packing relationships, including two affiliated suppliers. We sell primarily to food service distributors. We also sell our products to wholesalers, retail establishments and seafood distributors.

 

Recent Events

 

British Columbia Civil Claim

 

On March 4, 2026, the Company, through TOBC, filed a Notice of Application in the Supreme Court of British Columbia (the “Court”) in connection with a dispute with their landlords Steven Atkinson and Janet Atkinson (the “Landlords”) of the property located at 2930 Jameson Road, Nanaimo, B.C. V9R 6W8. The application seeks, among other things, reconsideration and setting aside of a February 23, 2026 order that terminated the Company’s lease and granted the landlords immediate possession of the property. The Company also seeks relief from forfeiture and reinstatement of the lease, or alternatively other interim and related relief. The Company’s application asserts that the order was made following a hearing at which the Company did not appear and that certain relevant facts were not before the Court, including that basic rent payments had been made within the time permitted under the lease and that the parties were engaged in mediation regarding a dispute over alleged additional rent & operational contradicting views under the lease. A hearing on the application was held on March 9, 2026. The presiding judge reserved judgment, and a decision has not yet been issued. The Company cannot predict the outcome of the proceeding or whether the requested relief will be granted.

 

Indonesian Supplier Civil Claim

 

The Company, together with its subsidiaries, has initiated legal proceedings against an Indonesian seafood supplier, in the U.S. District Court for the Southern District of Florida. The complaint alleges breach of contract, violation of the Florida Deceptive and Unfair Trade Practices Act, and unjust enrichment arising from shipments delivered in 2022. According to the complaint, certain product lots supplied were determined to be rancid and unmarketable following customer complaints and third-party laboratory testing. The Company asserts that it incurred approximately $0.250 million in direct product losses, in addition to other related costs. The Company is seeking monetary damages, including consequential damages, as well as other relief. The outcome of this matter is currently uncertain, and no assurance can be given regarding the timing or ultimate resolution.

 

22

 

 

Results of Operations

 

The following discussion and analysis of financial condition and results of operations of the Company is based upon, and should be read in conjunction with, the financial statements and accompanying notes elsewhere in this Quarterly Report.

 

Three months ended March 31, 2026 and 2025

 

Net Revenue. Revenue for the three months ended March 31, 2026 decreased 74.0% to $250,259 as compared to $960,758 for the three months ended March 31, 2025 as a result of a decrease in poundage sold during the three months ended March 31, 2026.

 

Cost of Goods Sold. Cost of goods sold for the three months ended March 31, 2026 decreased to $241,512 as compared to $869,114 for the three months ended March 31, 2025. This decrease is attributable to the decrease in poundage sold in the cost of goods and the adjustment to inventory allowance during the three months ended March 31, 2026 compared to the three months ended March 31,2025.

 

Gross Profit. Gross profit for the three months ended March 31, 2026 decreased to $8,747 as compared to $91,644 in the three months March 31, 2025. This decrease is due to the adjustment to inventory allowance recorded during the three months ended March 31, 2026 compared to the three months ended March 31, 2025.

 

Salaries and Wages Expense. Salaries and wages expense decreased to $182,877 for the three months ended March 31, 2026 as compared to $270,284 for the three months ended March 31, 2025. This decrease is mainly attributable to a reduction in the number of employees as of March 31, 2026.

 

Director Compensation. Director compensation was $138,012 for the three months end March 31, 2026 and 2025, resulting in no change compared to the prior-year period.

 

Depreciation and Amortization. Depreciation and amortization expense was $6,386 for the three months ended March 31, 2026 and 2025, resulting in no change compared to the prior-year period..

 

Other Operating Expense. Other operating expense decreased to $201,565 for the three months ended March 31, 2026 from $648,483 for the three months ended March 31, 2025. This decrease is mainly attributable to legal and professional expenses related to our business operations.

 

Other Income. Other income decreased for the three months ended March 31, 2026 to $1,280 from $6,615 for the three months ended March 31, 2025. This decrease is mainly attributable to other non-operating income recognized during the three months ended March 31, 2025.

 

Change in Fair Value of Derivatives and Warrants Liabilities. Change in fair value of derivatives and warrants liabilities decreased to $0 for the three months ended March 31, 2026 from $14,090 for the three months ended March 31, 2025. This decrease is attributable to the fair value measurement for the derivative liability for the three months ended March 31, 2026.

 

Change in Fair Value of Convertible Notes. Change in fair value of convertible notes increased to a loss of $136,729 for the three months ended March 31, 2026 from $0 for the three months ended March 31, 2025. This increase is attributable to fair value measurement for convertible notes as of March 31, 2026.

 

Loss on Settlement of Debt. Loss on settlement of debt increased to $47,241 for the three months ended March 31, 2026 from $41,066 for the three months ended March 31, 2025. The increase is attributable to convertible note payments during the three months ended March 31, 2026.

Interest Expense. Interest expense decreased to $32,530 for the three months ended March 31, 2026 from $208,048 for the three months ended March 31, 2025. The decrease is attributable to the decrease in amortization of debt discount and interest paid and accrued on the notes.

 

Net Loss. Net loss was $735,313 for the three months ended March 31, 2026 as compared to $1,199,930 for the three months ended March 31, 2025. The decrease in net loss is primarily attributable to the change in fair value of derivative and warrant liabilities and the interest expense.

 

23

 

 

Liquidity and Capital Resources

 

The Company had cash of $16,948 as of March 31, 2026. At March 31, 2026, the Company had a working capital deficit of $3,134,850 and the Company’s primary sources of liquidity consisted of inventory of $355,572 and accounts receivable of $93,425.

 

The Company has historically financed its operations through the cash flow generated from operations, capital investment, notes payable and a working capital line of credit.

 

Cash (Used in) Operating Activities. Cash used in operating activities during the three months ended March 31, 2026 was $48,670 as compared to cash used in operating activities of $392,550 for the three months ended March 31, 2025. The decrease is primarily attributable to decrease in inventory of $88,842 and decrease in other current assets of $154,411, offset by the increase in receivable of $58,424 and decrease in payables and accruals of $223,037 for the three months ended March 31, 2026 compared with the three months ended March 31, 2025.

 

Cash (Used in) Investing Activities. Cash used in investing activities for the three months ended March 31, 2026 was $0 as compared to cash used in investing activities of $9,914 for the three months ended March 31, 2025. The decrease was mainly attributable to no purchases of fixed assets for the three months ended March 31, 2026 compared to the purchases of fixed assets for the three months ended March 31, 2025.

 

Cash Provided by Financing Activities. Cash provided by financing activities for the three months ended March 31, 2026 was $70,455 as compared to cash provided by financing activities of $80,167 for the three months ended March 31, 2025. The decrease is mainly attributable due to the decreased repayments of short-term loans and less proceeds from short-term loan during the three months ended March 31, 2026.

 

Lind Global Fund II LP investment

 

On May 30, 2023, the Company entered into a securities purchase agreement with Lind pursuant to which the Company issued to Lind a secured, two-year, interest free convertible promissory note in the principal amount of $1,200,000 (the “Lind Note”) and a warrant (the “Lind Warrant”) to purchase 8,701 shares of common stock of the Company commencing six months after issuance and exercisable for five years at an exercise price of $122.50 per share, for the aggregate funding amount of $1,000,000. The Lind Warrant includes cashless exercise and full ratchet anti-dilution provisions. In connection with the issuance of the Lind Note and the Lind Warrant, the Company paid Lind a $50,000 commitment fee. The proceeds from the sale of the Note and Warrant are for general working capital purposes.

 

On July 27, 2023, the Company, entered into a First Amendment to the securities purchase agreement (the “Purchase Agreement Amendment”) with Lind, pursuant to which the Company amended the securities purchase agreement, entered into with Lind as of May 30, 2023 in order to permit the issuance of further senior convertible promissory notes in the aggregate principal amount of up to $1,800,000 and warrants in such aggregate amount as the Company and Lind shall mutually agree.

 

Pursuant to the Purchase Agreement Amendment, the Company issued to Lind a two-year, interest free convertible promissory note in the principal amount of $300,000 and a warrant to purchase 3,505 shares of common stock of the Company, for the aggregate amount of $250,000. In connection with the issuance of the note and the warrant, the Company paid a $12,500 commitment fee. The proceeds from the sale of the note and warrant are for general working capital purposes.

 

On August 3, 2024 the Company and Lind entered into a waiver and acknowledgement agreement.

 

The Company and Lind previously entered into that certain Securities Purchase Agreement, dated as of May 20, 2023, as amended on July 27, 2023 pursuant to which the Company issued Lind a senior convertible promissory note in the principal amount of $300,000. Each of the Company and Lind acknowledge that the amounts owing under the convertible promissory note as of the filing of the Waiver Agreement is equal to $355,500.

 

During the three months ended March 31, 2026, there were no payments to the note principal. As of March 31, 2026 and December 31, 2025, the outstanding balance on the notes was $55,500.

 

Debt with Third-Party Investors

 

On January 28, 2025, the Company entered into a subordinated business loan and security agreement with a third-party lender and collateral agent providing for a term loan in the principal amount of $420,000, with total repayment of principal and interest of $596,400 and a maturity date of August 15, 2025. Commencing February 7, 2025, the Company is required to make weekly payments of $21,300 until the maturity date. The loan may be prepaid subject to a prepayment fee. In connection with the loan, the Company paid an administrative agent fee of $20,000, which was recorded as a debt discount and is being amortized over the term of the loan. For the three months ended March 31, 2026, the Company made no principal and interest payments. The outstanding balance on the loan was $266,000 as of March 31, 2026.

 

25

 

 

On January 28, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $149,650 with an original issue discount of $19,650 (the “January 2025 Convertible Note”). The January 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $19,454 paid upon issuance and a maturity date of October 30, 2025. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the January 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the January 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company may not, without written consent, sell, lease, or otherwise dispose of any significant portion of its assets except in the ordinary course of business. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the January 2025 Convertible Note. For the three months ended March 31, 2026, the Company made principal payments on the loan totaling $6,860 and no interest payments. The outstanding balance of on the loan was $53,312 as of March 31, 2026.

 

On August 25, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $169,500 with an original issue discount of $25,425 (the “August 2025 Convertible Note”). The August Convertible Note has an interest rate of 13% with a one-time interest payment of $22,035 paid upon issuance and a maturity date of August 25, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the August Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the August Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the August Convertible Note. For the three months ended March 31, 2026, the Company made no principal payments and interest payments of $8,628. The outstanding balance of on the note was $169,500 as of March 31, 2026. Interest expense related to the loan $14,137 for the three months ended March 31, 2026.

 

On December 5, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $73,025 with an original issue discount of $9,525 (the “December 2025 Convertible Note”). The December 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $9,493 paid upon issuance and a maturity date of December 5, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the December 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 22% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the December 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 75% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the December 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance of on the note was $73,025 as of March 31, 2026.

 

On September 16, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $47,059 with an original issue discount of $7,059 (the “September 16, 2025 Convertible Note”). The September 16, 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $6,118 paid upon issuance and a maturity date of June 16, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the September 16, 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the September 16, 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September 16, 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $47,059. Interest expense related to the loan $2,039 for the three months ended March 31, 2026.

 

On November 13, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $40,000 with an original issue discount of $6,000 (the “November 2025 Convertible Note”). The November 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $5,200 paid upon issuance and a maturity date of August 13, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the November 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the November 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the November 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $40,000. Interest expense related to the loan $1,733 for the three months ended March 31, 2026.

 

On September 18, 2025, the Company issued a convertible promissory note to a third-party investor in the principal amount of $47,059 with an original issue discount of $7,059 (the “September 18, 2025 Convertible Note”). The September 18, 2025 Convertible Note has an interest rate of 13% with a one-time interest payment of $6,118 paid upon issuance and a maturity date of June 16, 2026. The proceeds from the issuance were used for general working capital purposes. Upon the occurrence of an event of default as described in the September 18, 2025 Convertible Note, the note will become immediately due and payable at a default interest rate of 24% of the then outstanding principal amount of the note. Additionally, the third-party investor will have the right to convert all or any part of the outstanding and unpaid amount of the September 18, 2025 Convertible Note into shares of the Company’s common stock at a conversion price of 65% of the market price as described in the note. The Company will reserve a sufficient number of shares to provide for the issuance of shares upon the full conversion of the September 18, 2025 Convertible Note. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $47,059. Interest expense related to the loan $2,039 for the three months ended March 31, 2026.

 

26

 

 

On March 10, 2026, the Company issued a convertible promissory note to a third-party investor in the principal amount of $57,500 (the “March 2026 Convertible Note”). The note was issued with an original issue discount of $7,500, resulting in net proceeds to the Company of $50,000. The note includes a one-time interest charge of $7,475 and has a maturity date of December 10, 2026. Upon the occurrence of an event of default, the note accrues interest at a rate of up to 24% per annum on the outstanding principal balance. The note may be prepaid in accordance with its terms and may also be convertible into shares of the Company’s common stock, subject to the provisions of the note agreement. For the three months ended March 31, 2026, the Company made no principal and interest payments on the note. The outstanding balance on the note was $57,500.

 

August 2024 Private Placement Offering

 

In August, 2024, the Company entered into securities purchase agreements (each a “Securities Purchase Agreement”) with each of Quick Capital, LLC, a Wyoming limited liability company (“Quick Capital”) and Jefferson Street Capital, LLC, a New Jersey limited liability company (“Jefferson”) whereby we issued promissory notes in the aggregate principal amount of $550,000 (the “August Private Placement Offering”).

 

The Company agreed to issue to Quick Capital and Jefferson up to 39,300 shares of our Common Stock as a “Commitment Fee”.

 

As part of the August Private Placement Offering, the Company issued two promissory notes each in the principal amount of $275,000 with an original issue discount of $25,000 (the “Private Placement Notes”). The Private Placement Notes have a one-time interest payment of $27,500. Thereafter, any principal amount of interest which is not paid upon maturity will accrue at a rate of the lesser of (i) sixteen percent (16%) per annum, or (ii) the maximum amount permitted by law from the due date thereof until the same is paid. The Private Placement Notes have a maturity date of 10 months after issuance and the proceeds from the notes are for general corporate purposes. The Company agreed to issue to each of Quick Capital and Jefferson 19,650 shares of Common Stock as additional consideration for entering into Private Placement Notes.

 

The investors have the right, at any time on or following the earlier of (i) the date that any of the shares are registered for resale under a registration statement of the Company or (ii) the date that is six (6) months after the issue date, to convert all or any portion of the then outstanding and unpaid principal and interest into fully paid and non-assessable shares of our Common Stock. The conversion price shall be $1.50, subject to adjustments. We have agreed to reserve a sufficient number of Common Stock (initially, 2,000,000 shares) for issuance upon conversion of the Private Placement Notes in accordance with their terms.

 

If an event of default occurs under the Private Placement Notes, the investors have the right to convert all amounts outstanding under the notes at any time thereafter into shares of Common Stock at the lesser of (i) the then applicable conversion price under the notes or (ii) the Market Price. “Market Price” shall mean 85% of the lowest VWAP on any trading day during the ten (10) trading days prior to the respective conversion date. “VWAP” means, for any security as of any date, the dollar volume-weighted average price for such security on the principal market during the period beginning at 9:30 a.m., Eastern Standard Time, and ending at 4:00 p.m., Eastern Standard Time, as reported by Quote stream or other similar quotation service provider designated by the investors.

 

The Company may prepay the Private Placement Notes at any time with fifteen (15) trading days prior written notice (the “Prepayment Notice Period”). During the Prepayment Notice Period, the investor shall have the right to convert all or any portion of the Private Placement Notes pursuant to the terms of the notes, including the amount of the Private Placement Notes to be prepaid. If the Company exercises its right to prepay the notes, the Company shall make payment to the investor of an amount in cash equal to the sum of: (i) 100% multiplied by the principal amount then outstanding plus (ii) accrued and unpaid interest on the principal amount to the Prepayment Notice Date, and (iii) $750 to reimburse the investor for administrative fees.

 

If the Company delivers a prepayment notice and fails to pay the applicable prepayment amount, the Company shall forever forfeit its right to prepay any part of the Private Placement Notes.

 

27

 

 

The Private Placement Notes have mandatory monthly payments of $43,200. The initial payments are due on November 9, 2024 and November 12, 2024, respectively.

 

The Company’s failure to comply with the material terms of the Private Placement Notes will be considered an event of default and the principal sum of the Private Placement Notes will become immediately due and payable at an amount equal to the principal amount then outstanding plus accrued interest (including any default interest) through the date of full repayment multiplied by 135%, as well as all costs, all without demand, presentment or notice, unless expressly waived by the investor.

 

The investors may assign their rights to any “accredited investor” (as defined in Rule 501(a) of the 1933 Act) in a private transaction or to any of its affiliates without the consent of the Company.

 

While the Private Placement Notes remain outstanding, we shall not, without the investor’s written consent (i) (a) pay, declare or set apart for such payment, any dividend or other distribution on shares of capital stock other than dividends on shares of Common Stock solely in the form of additional shares of Common Stock or (b) directly or indirectly or through any subsidiary make any other payment or distribution with respect to its capital stock except for distributions pursuant to any shareholders’ rights plan which is approved by a majority of the Company’s disinterested directors, (ii) redeem, repurchase or otherwise acquire (whether for cash or in exchange for property or other securities or otherwise) in any one transaction or series of related transactions any shares of capital stock of the Company or any warrants, rights or options to purchase or acquire any such shares, or repay any indebtedness of the investor (iii) advance any loans made in the ordinary course of business in excess of $100,000, (iv) sell, lease or otherwise dispose of any significant portion of our assets outside the ordinary course of business, and (v) enter into any transaction or arrangement structured in accordance with, based upon, or related or pursuant to, in whole or in part, either Section 3(a)(9) or Section 3(a)(10) of the Securities Act.

 

In conjunction with the August Private Placement Offering, the Company entered into a registration rights agreement with each of Quick Capital and Jefferson. The Company agreed to file a registration statement with the Securities and Exchange Commission to register the re-sale of the maximum number of shares of Common Stock covered in the August Private Placement Offering within sixty (60) calendar days from the date of execution.

 

During the three months ended March 31, 2026, the Company made aggregate principal payments on the Private Placement Notes of $29,242 of which was paid through the issuance of an aggregate of 43,152,282 shares of common stock. The outstanding balance on the loan was $33,006 as of March 31, 2026.

 

Unaffiliated Note

 

On October 29, 2025, the Company entered into a promissory note agreement with an unaffiliated third-party lender for aggregate principal of $50,000. The note bears interest at a rate of 32% per annum and matures on July 29, 2026. The proceeds are for general working capital. Upon the occurrence of an event of default as described in the note, the note will become immediately due and payable at a default interest rate of 25% of the then outstanding principal amount of the note. For the three months ended March 31, 2026, the Company made principal payments of $500 and no interest payments. The outstanding balance on the note was $41,419 as of March 31, 2026.

 

Vehicle Loan

 

On December 7, 2024, the Company entered into a financing loan in connection with the purchase of a company vehicle. The loan has a principal amount of $69,299, bears interest at an annual rate of 9.34%, and is repayable in monthly installments of $1,450, including principal and interest, over a term of 60 months. For the three months ended March 31, 2026, the Company made no principal payments on the loan and interest payments of $1,222. The outstanding balance on the loan was $56,185 as of March 31, 2026.

 

The Company is evaluating potential opportunities to seek refunds, duty drawbacks, exclusions, and other recoveries related to tariffs paid on certain imported products and raw materials. The Company is currently gathering supporting documentation and assessing eligibility requirements under applicable laws and regulations.

 

While the Company believes it may be entitled to pursue certain recoveries, no claims have been submitted as of July 16, 2026, and the amount and timing of any potential recoveries remain uncertain. Accordingly, the Company has not recognized any assets or benefits related to potential tariff recoveries in its consolidated financial statements.

 

Off-Balance Sheet Arrangements

 

We currently have no off-balance sheet arrangements.

 

28

 

 

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

ITEM 4. CONTROLS AND PROCEDURES

 

Evaluation of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, as of March 31, 2026, we conducted an evaluation of our disclosure controls and procedures, as such term is defined under Rule 13a-15(e) and Rule 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended. Based on this evaluation our principal executive officer and principal financial officer have concluded that based on the material weaknesses discussed below our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed by us in reports filed or submitted under the Securities Exchange Act were recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and that our disclosure controls are not effectively designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act is accumulated and communicated to management, including our principal executive officer and principal financial officer, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

 

The matters involving internal controls and procedures that our management considered to be material weaknesses under the standards of the Public Company Accounting Oversight Board were:

 

● inadequate control over the monitoring of inventory maintained in the Company’s third-party warehouse;

 

ineffective controls over the Company’s financial close and reporting process; and

 

● inadequate segregation of duties consistent with control objectives, including lack of personnel resources and technical accounting expertise within the accounting function of the Company.

 

Management’s Remediation Initiatives

 

In an effort to remediate the identified material weaknesses and other deficiencies and enhance our internal controls, we plan to further initiate, the following measures, subject to the availability of required resources:

 

● We plan to create a position to segregate duties consistent with control objectives and hire personnel resources with technical accounting expertise within the accounting function; and

 

● We plan to create an internal control framework that will address financial close and reporting process, among other procedures.

 

Changes in Internal Control over Financial Reporting

 

During the period covered by this Quarterly Report, there were no changes in our internal controls over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

29

 

 

PART II – OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

There are no material pending legal proceedings to which we are a party or in which any director, officer or affiliate of ours, any owner of record or beneficially of more than 5% of any class of our voting securities, or security holder is a party adverse to us or has a material interest adverse to us.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information under this item.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

On January 16, 2026, the Company issued an aggregate of 4,085,714 shares of common stock, to the designee of ClearThink Capital for consulting services provided to the Company.

 

During the three months ended March 31, 2026, the Company issued an aggregate of 43,152,282 shares of common stock to Quick Capital as partial conversion of $29,242 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2026, the Company issued 9,910,149 shares of common stock to Diagonal as partial conversion of $6,860 principal pursuant to the convertible promissory note.

 

During the three months ended March 31, 2026, the Company issued an aggregate of 15,100,000 shares of common stock to Labrys Fund as conversion of $8,627 interest pursuant to the convertible promissory note.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

None.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable.

 

ITEM 5. OTHER INFORMATION

 

During the three months ended March 31, 2026, none of the Company’s directors or officers adopted or terminated any contract, instruction, or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act or any non-Rule 10b5-1 trading arrangements as defined in Item 408(a) of Regulation S-K.

 

ITEM 6. EXHIBITS

 

Exhibit No.   Description
     
31.1   Certification of Principal Executive Officer and Principal Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certifications of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

30

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BLUE STAR FOODS CORP.
     
Dated: July 16, 2026 By: /s/ John Keeler
  Name: John Keeler
  Title: Executive Chairman and Chief Executive Officer (Principal Executive Officer, Principal Financial Officer and Accounting Officer)

 

31